Real-world antithrombotic strategies in patients with atrial fibrillation and recently developed acute coronary syndrome.

Both the thrombotic and bleeding risk scores were numerically higher in the Warfarin group compared to DOAC group, although its difference did not reach statistical significance.

also in 111,027 other papers